Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?

por Sant, Grannum R., Knopf, Kevin B., Albala, David M.
Publicado 2017

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery

por Badani, Ketan K, Thompson, Darby J, Brown, Gordon, Holmes, Daniel, Kella, Naveen, Albala, David, Singh, Amar, Buerki, Christine, Davicioni, Elai, Hornberger, John
Publicado 2015

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines

por Shore, Neal D., Antonarakis, Emmanuel S., Cookson, Michael S., Crawford, E. David, Morgans, Alicia K., Albala, David M., Hafron, Jason, Harris, Richard G., Saltzstein, Daniel, Brown, Gordon A., Henderson, Jonathan, Lowentritt, Benjamin, Spier, Jeffrey M., Concepcion, Raoul
Publicado 2020

Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study

por Kwon, Young Suk, Ha, Yun-Sok, Modi, Parth K., Salmasi, Amirali, Parihar, Jaspreet S., Patel, Neal, Faiena, Izak, May, Michael, Lee, David I., Llukani, Elton, Patrick, Tuliao, Rha, Koon Ho, Ahlering, Thomas, Skarecky, Douglas, Ahn, Hanjong, Choi, Seung-Kwon, Park, Sejun, Jeon, Seong Soo, Ou, Yen-Chuan, Eun, Daniel, Manucha, Varsha, Albala, David, Badani, Ketan, Yuh, Bertram, Ruel, Nora, Kim, Tae-Hwan, Kwon, Tae Gyun, Marchalik, Daniel, Hwang, Jonathan, Kim, Wun-Jae, Kim, Isaac Yi
Publicado 2015